Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry titled "Bioequivalence Recommendations for Specific Products" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.
- quotes — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry titled "Bioequivalence Recommendations for Specific Products" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance. (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — url: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — source-subject: federal-register:2026-23692 (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — source-edition: ni:///sha-256;CnXGVnc86_22qwtT8xrb9bnoLqrGT7L0THrUvLkQaSM (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — source-metadata: {"subject":"federal-register:2026-23692","revision":"ni:///sha-256;CnXGVnc86_22qwtT8xrb9bnoLqrGT7L0THrUvLkQaSM","documentNumber":"2026-23692","documentUrl":"https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability","title":"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","documentType":"Notice","publicationDate":"2026-11-20","publicationDatePrecision":"civil-day","agencies":["Food and Drug Administration","Health and Human Services Department"],"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The draft guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry titled \"Bioequivalence Recommendations for Specific Products\" that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The draft guidances identified in this notice were developed using the process described in that guidance.","commentsCloseOn":"2027-01-19","commentDeadlineFieldRequested":true,"effectiveOn":null,"sourceAction":"Notice of availability.","federalRegisterCitation":"91 FR 75332","docketIds":["Docket No. FDA-2007-D-0369"],"regulationIdNumbers":[],"cfrReferences":[],"correctionOf":null,"corrections":[],"source":{"originalApiUrl":"https://www.federalregister.gov/api/v1/documents.json?conditions%5Bpublication_date%5D%5Bgte%5D=2026-11-13&conditions%5Bpublication_date%5D%5Blte%5D=2026-11-20&per_page=100&page=1&order=newest&fields%5B%5D=document_number&fields%5B%5D=title&fields%5B%5D=type&fields%5B%5D=abstract&fields%5B%5D=html_url&fields%5B%5D=publication_date&fields%5B%5D=agencies&fields%5B%5D=comments_close_on&fields%5B%5D=effective_on&fields%5B%5D=action&fields%5B%5D=citation&fields%5B%5D=regulation_id_numbers&fields%5B%5D=cfr_references&fields%5B%5D=docket_ids&fields%5B%5D=correction_of&fields%5B%5D=corrections","originalResponseDigest":"sha256:1160a7c5dcdb16395e0cd25aba8ff363c881eb7177b568d666e61927e2b90a0d","originalResponseUri":"ni:///sha-256;EWCnxdzbFjleDNJauo_zY8iB63F3tWjWZuYZJ-K5Cg0","normalizedLotDigest":"sha256:d75a61adece848cba32aa7572ec719e9a384b2838a263e8dfacbda7c7673dbcc","observedAt":"2026-11-20T11:57:04.187Z","provider":"https://www.federalregister.gov","publisher":{"name":"Office of the Federal Register","source":"https://www.federalregister.gov/reader-aids/developer-resources/rest-api","reproduction":"https://www.archives.gov/federal-register/faqs","officialNotice":"The source Federal Register edition, not this derived JSON, is authoritative. No government endorsement."},"evidenceClass":"source-dated government metadata, independently replayable from original HTTP bytes held by the source acquisition run"}} (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)
- quotes — editorial-standing: source metadata; editorial acceptance pending (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/20/2026-23692/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability; status: unverified)